Delivery Order SPE2DB20D3103-SPE2DB26FL4L5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,496.42. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $13,807.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. The order is scheduled for completion by September 9, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $29,588.62. This firm fixed-price delivery order, which is expected to conclude by August 15, 2025, represents a competitively awarded, non-set-aside contract with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award demonstrates the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,932.84 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,940.38. This firm fixed-price delivery order, which is not set-aside and represents the culmination of competitive procurement, is scheduled for completion by August 7, 2025. The award supports the federal medical supply chain, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $4,438.86. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and no set-aside designation was used in the competitive award process. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $17,437.91. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $17,122.81. This is a non-set-aside competitive award with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $19,464.52 to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Otezla 30 mg tablets (60 count). This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Otezla 30 mg tablets (60-count) with a contract value of $11,917.90. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, demonstrating the contractor's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4L5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $6,367.80. This firm fixed price delivery order is scheduled for completion by October 31, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of delivery orders covering brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 10/30/25 |